Literature DB >> 19660392

Detecting occult coronary artery disease followed by early coronary artery bypass surgery in patients with diabetic retinopathy: report from a diabetic retinocoronary clinic.

Takayuki Ohno1, Osamu Kinoshita, Hideo Fujita, Satoshi Kato, Akira Hirose, Takashi Sigeeda, Kazuyoshi Otomo, Jiro Ando, Takashi Kadowaki, Makoto Araie, Ryozo Nagai, Shinichi Takamoto.   

Abstract

OBJECTIVES: We hypothesized that a large number of patients with diabetic retinopathy who could benefit greatly from early coronary artery bypass grafting would not be identified.
METHODS: Patients with diabetic retinopathy receiving ophthalmologic care as outpatients in our hospital in whom coronary artery disease was not previously suspected were referred randomly to the diabetic retinocoronary clinic and were asked to participate in diagnostic tests, including an exercise treadmill test and exercise thallium scintigraphy or coronary computed tomography. Patients who had type 1 diabetes mellitus, required hemodialysis, or both were excluded from this study. A definitive diagnosis of coronary artery disease was confirmed by means of coronary angiography.
RESULTS: Of 214 patients with diabetic retinopathy, 55 (25.7%) were confirmed as having significant stenotic coronary artery disease. Patients with angiographically confirmed coronary disease were older than those with negative results on diagnostic tests (62.2 + or - 9.8 vs 57.9 + or - 10.3 years, P = .01). Fifteen had 1-vessel disease, 17 had 2-vessel disease, 14 had 3-vessel disease, 1 had left main trunk plus 1-vessel disease, 2 had left main trunk plus 2-vessel disease, and 5 had left main trunk plus 3-vessel disease. Eight patients had left main trunk disease, and 18 patients with non-left main trunk disease had proximal left anterior descending coronary artery (LAD) disease. Forty-two patients showed indications of coronary revascularization (coronary artery bypass grafting in 17 and percutaneous coronary intervention in 25). During the entire follow-up (287.6 + or - 183.2 days) of 39 patients undergoing coronary revascularization, all were alive without myocardial infarction, but 8 experienced vitreous hemorrhage.
CONCLUSIONS: Approximately 25% of patients with diabetic retinopathy receiving ophthalmologic care as outpatients have a significant stenotic coronary artery disease. Of the total diabetic population, a large number of patients with diabetic retinopathy who show strong indications for early coronary artery bypass grafting might well go unrecognized. Copyright 2010 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19660392     DOI: 10.1016/j.jtcvs.2009.04.005

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  2 in total

1.  Candidate gene association study for diabetic retinopathy in persons with type 2 diabetes: the Candidate gene Association Resource (CARe).

Authors:  Lucia Sobrin; Todd Green; Xueling Sim; Richard A Jensen; E Shyong Tai; Wan Ting Tay; Jie Jin Wang; Paul Mitchell; Niina Sandholm; Yiyuan Liu; Kustaa Hietala; Sudha K Iyengar; Matthew Brooks; Monika Buraczynska; Natalie Van Zuydam; Albert V Smith; Vilmundur Gudnason; Alex S F Doney; Andrew D Morris; Graham P Leese; Colin N A Palmer; Anand Swaroop; Herman A Taylor; James G Wilson; Alan Penman; Ching J Chen; Per-Henrik Groop; Seang-Mei Saw; Tin Aung; Barbara E Klein; Jerome I Rotter; David S Siscovick; Mary Frances Cotch; Ronald Klein; Mark J Daly; Tien Y Wong
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-09-29       Impact factor: 4.799

2.  Achieving LDL cholesterol target levels <1.81 mmol/L may provide extra cardiovascular protection in patients at high risk: Exploratory analysis of the Standard Versus Intensive Statin Therapy for Patients with Hypercholesterolaemia and Diabetic Retinopathy study.

Authors:  Hiroshi Itoh; Issei Komuro; Masahiro Takeuchi; Takashi Akasaka; Hiroyuki Daida; Yoshiki Egashira; Hideo Fujita; Jitsuo Higaki; Ken-Ichi Hirata; Shun Ishibashi; Takaaki Isshiki; Sadayoshi Ito; Atsunori Kashiwagi; Satoshi Kato; Kazuo Kitagawa; Masafumi Kitakaze; Takanari Kitazono; Masahiko Kurabayashi; Katsumi Miyauchi; Tomoaki Murakami; Toyoaki Murohara; Koichi Node; Susumu Ogawa; Yoshihiko Saito; Yoshihiko Seino; Takashi Shigeeda; Shunya Shindo; Masahiro Sugawara; Seigo Sugiyama; Yasuo Terauchi; Hiroyuki Tsutsui; Kenji Ueshima; Kazunori Utsunomiya; Masakazu Yamagishi; Tsutomu Yamazaki; Shoei Yo; Koutaro Yokote; Kiyoshi Yoshida; Michihiro Yoshimura; Nagahisa Yoshimura; Kazuwa Nakao; Ryozo Nagai
Journal:  Diabetes Obes Metab       Date:  2018-12-06       Impact factor: 6.577

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.